Cambodia vs Iraq: Cause of death, by non-communicable diseases, ages 5-14, male
Cambodia
28.2%
in 2021
Iraq
27.5%
in 2021
Cambodia rank
110th
Iraq rank
113th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Cambodia
- Iraq
How they compare
Cambodia currently reports 28.2% against 27.5% in Iraq, a difference of 0.7%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Iraq ahead.
Cambodia ranks 110th and Iraq ranks 113th of 185 countries.
Across the 3 decades both report, Cambodia averaged higher in 2 and Iraq in 1.
Head to head by decade
| Decade | Cambodia | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.2% | 26.3% | 10.1% | Iraq |
| 2010s | 24.6% | 22.6% | 2.0% | Cambodia |
| 2020s | 28.5% | 28.1% | 0.4% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Cambodia or Iraq?
- Cambodia, at 28.2% against 27.5% in Iraq as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Cambodia and Iraq?
- 0.7%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Iraq?
- 6 years are reported by both, from 2000 to 2021.
- How do Cambodia and Iraq rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Cambodia ranks 110th and Iraq ranks 113th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.